12.03
0.04 (0.33%)
| Penutupan Terdahulu | 11.99 |
| Jumlah Dagangan | 44,833 |
| Harga / Jualan (P/S) | 1.54 |
| Harga / Buku (P/B) | 0.650 |
| Julat 52 Minggu |
| Margin Keuntungan | -41.07% |
| Margin Operasi (TTM) | -39.88% |
| EPS Cair (TTM) | -4.40 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -25.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.18% |
| Nisbah Semasa (MRQ) | 3.53 |
| Aliran Tunai Operasi (OCF TTM) | -30.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 9.06 M |
| Pulangan Atas Aset (ROA TTM) | -5.06% |
| Pulangan Atas Ekuiti (ROE TTM) | -17.25% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - General (US) | Bercampur | Menaik |
| Drug Manufacturers - General (Global) | Bercampur | Menaik | |
| Stok | Amarin Corporation plc | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -0.67 |
|
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - General |
| % Dimiliki oleh Orang Dalam | 1.88% |
| % Dimiliki oleh Institusi | 17.94% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Waterfront Wealth Inc. | 30 Jun 2026 | 213,949 |
| Lcm Capital Management Inc | 30 Jun 2026 | 51,362 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |